2026 Francisco Ruiz-Cabello: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	68	2629	2420	28	28	221	12864

Francisco Ruiz-Cabello publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Francisco Ruiz-Cabello sits on this spectrum.

62 publications 807+

This scientist: 221 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Francisco Ruiz-Cabello D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Francisco Ruiz-Cabello sits on this spectrum.

40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Francisco Ruiz-Cabello is affiliated with the University of Granada in Spain. Their research spans multiple fields, primarily focusing on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work extensively covers subfields including Immunology, Oncology, Molecular Biology, Genetics, and Infectious Diseases.

Their main research topics reflect a broad engagement with immune system functionality and disease mechanisms. These include:

Immune Cell Function and Interaction
Cancer Immunotherapy and Biomarkers
Liver Disease Diagnosis and Treatment
Immunotherapy and Immune Responses
Drug-Induced Hepatotoxicity and Protection
SARS-CoV-2 and COVID-19 Research
Genetic Associations and Epidemiology

Francisco Ruiz-Cabello has contributed to several recent publications, highlighting their involvement in immunology, cancer research, and infectious diseases. Selected recent papers include:

"HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy" (2021), published in Cellular and Molecular Immunology
"Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset" (2020), published in Frontiers in Immunology
"Consensus on Recommendations for Safe Sexual Activity during the COVID-19 Coronavirus Pandemic" (2020), published in Journal of Clinical Medicine
"Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients" (2021), published in Journal of Microbiology Immunology and Infection
"HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine" (2022), published in Vaccines

The scientist frequently collaborates with peers in their field. Notable co-authors include:

Juan Francisco Gutiérrez-Bautista
Federico Garrido
Natalia Aptsiauri
Francisco Perea
Per Anderson

Francisco Ruiz-Cabello's research appears in a range of publication venues, with multiple contributions to international journals. These venues include:

International Journal of Molecular Sciences
Cancers
eLife
Clinical Kidney Journal
Cellular and Molecular Immunology

Best Publications

IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS

Federico Garrido;Francisco Ruiz-Cabello;Teresa Cabrera;Juan J. Pérez-Villar

1026
Citations
Natural history of HLA expression during tumour development

Federico Garrido;Teresa Cabrera;Angel Concha;Susan Glew

610
Citations
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury is Influenced by Multiple HLA Class I and II Alleles

M. Isabel Lucena;Mariam Molokhia;Yufeng Shen;Thomas J. Urban

514
Citations
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

Ignacio Algarra;Angel García-Lora;Teresa Cabrera;Francisco Ruiz-Cabello

386
Citations
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.

Alfonso Serrano;Silvia Tanzarella;Ilaria Lionello;Rosa Mendez

308
Citations
Analysis of HLA-E expression in human tumors

Rosario Marín;Francisco Ruiz-Cabello;Susana Pedrinaci;Rosa Méndez

238
Citations
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.

C M Cabrera;P Jiménez;T Cabrera;C Esparza

221
Citations
High frequency of altered HLA class I phenotypes in invasive breast carcinomas.

T. Cabrera;A. Collado;M.A. Fernandez;A. Ferron

221
Citations
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

R Benitez;Danièle Godelaine;M A Lopez-Nevot;F Brasseur

194
Citations
HLA class I antigens in human tumors.

Federico Garrido;Teresa Cabrera;Miguel Angel Lopez-Nevot;Francisco Ruiz-Cabello

190
Citations
Role of Altered Expression of HLA Class I Molecules in Cancer Progression

Natalia Aptsiauri;Teresa Cabrera;Rosa Mendez;Angel Garcia-Lor

181
Citations
Rejection versus escape: the tumor MHC dilemma

Federico Garrido;Francisco Ruiz-Cabello;Natalia Aptsiauri

178
Citations
MHC Class I Antigens and Immune Surveillance in Transformed Cells

Natalia Aptsiauri;Teresa Cabrera;Angel Garcia-Lora;Miguel Angel Lopez-Nevot

175
Citations
Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.

Jose María Romero;Pilar Jiménez;Teresa Cabrera;José Manuel Cózar

171
Citations
Multiple mechanisms underlie HLA dysregulation in cervical cancer.

C S Brady;J S Bartholomew;Deborah J Burt;Margaret F Duggan-Keen

168
Citations
Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.

Ana B. del Campo;Jon Amund Kyte;Javier Carretero;Svitlana Zinchencko

167
Citations
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

López-Nevot Ma;Esteban F;Ferrón A;Gutiérrez J

165
Citations
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

Rafael Carretero;José M. Romero;Francisco Ruiz-Cabello;Isabel Maleno

164
Citations
Analysis of HLA expression in human tumor tissues

Teresa Cabrera;Miguel Angel López-Nevot;Jose Juan Gaforio;Francisco Ruiz-Cabello

152
Citations
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

Pilar Jiménez;Julia Cantón;Antonia Collado;Teresa Cabrera

151
Citations

Frequent Co-Authors

Federico Garrido University of Granada

Manuel Romero-Gómez University of Seville

Alberto Orfao University of Salamanca

Julia Almeida University of Salamanca

Javier Martín Spanish National Research Council

Marcos González University of Salamanca

Anton W. Langerak Erasmus University Rotterdam

Miguel A. López-Nevot University of Granada

Peter L. Stern University of Manchester

Miguel Delgado University of Granada

External Links

Personal website of Francisco Ruiz-Cabello

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of healthcare careers, many of which can be pursued through flexible online degree options. For those interested in nursing, 12-month accelerated nursing programs offer a fast track to becoming a registered nurse while balancing other life commitments.

If you’re looking for an entry point into nursing with less time and cost, consider accredited LPN programs easy to get into. These programs provide practical training and essential skills needed to support patient care in various medical settings.

For advanced practice roles, exploring the easiest online nurse practitioner programs can help you gain specialized knowledge efficiently, preparing you for critical functions in healthcare teams.

Among these advanced options, the mental health field offers focused opportunities with top online PMHNP programs. These provide excellent clinical placement rates to develop expertise in psychiatric-mental health nursing, a growing area in immunology-related care.